Local estrogen replacement therapy in postmenopausal atrophic vaginitis: Efficacy and safety of low dose 17β-estradiol vaginal tablets

G. Mainini, C. Scaffa, M. Rotondi, E. M. Messalli, L. Quirino, A. Ragucci

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Purpose of investigation: To verify the effectiveness and safety of low-dose 17β-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis. Patients and methods: 325 postmenopausal women with atrophic vaginitis in estrogenic replacement therapy with 0.025 mg 17β-estradiol vaginal tablets, one application each day for two weeks, and a single application two times a week for the following 22 weeks (total treatment period: 24 weeks). Results: Most of the women reported an improvement of symptoms just after two weeks and minimal incidence of adverse reactions. No patients showed abnormal endometrial thickness and no one had to interrupt the treatment for abnormal uterine bleeding because of systemic absorption. Conclusion: Low-dose 17β-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis constitutes an extremely valid approach in terms of effectiveness and safety.

Original languageEnglish
Pages (from-to)111-113
Number of pages3
JournalClinical and Experimental Obstetrics and Gynecology
Volume32
Issue number2
Publication statusPublished - 2005

Fingerprint

Atrophic Vaginitis
Foams and Jellies Vaginal Creams
Estrogen Replacement Therapy
Estradiol
Safety
Therapeutics
Uterine Hemorrhage
Incidence

Keywords

  • 17β-estradiol vaginal tablets
  • Atrophic vaginitis
  • Estrogen replacement therapy

ASJC Scopus subject areas

  • Obstetrics and Gynaecology

Cite this

Local estrogen replacement therapy in postmenopausal atrophic vaginitis : Efficacy and safety of low dose 17β-estradiol vaginal tablets. / Mainini, G.; Scaffa, C.; Rotondi, M.; Messalli, E. M.; Quirino, L.; Ragucci, A.

In: Clinical and Experimental Obstetrics and Gynecology, Vol. 32, No. 2, 2005, p. 111-113.

Research output: Contribution to journalArticle

@article{1c0845a1fbcb49b1ac91c8d65a12c6cd,
title = "Local estrogen replacement therapy in postmenopausal atrophic vaginitis: Efficacy and safety of low dose 17β-estradiol vaginal tablets",
abstract = "Purpose of investigation: To verify the effectiveness and safety of low-dose 17β-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis. Patients and methods: 325 postmenopausal women with atrophic vaginitis in estrogenic replacement therapy with 0.025 mg 17β-estradiol vaginal tablets, one application each day for two weeks, and a single application two times a week for the following 22 weeks (total treatment period: 24 weeks). Results: Most of the women reported an improvement of symptoms just after two weeks and minimal incidence of adverse reactions. No patients showed abnormal endometrial thickness and no one had to interrupt the treatment for abnormal uterine bleeding because of systemic absorption. Conclusion: Low-dose 17β-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis constitutes an extremely valid approach in terms of effectiveness and safety.",
keywords = "17β-estradiol vaginal tablets, Atrophic vaginitis, Estrogen replacement therapy",
author = "G. Mainini and C. Scaffa and M. Rotondi and Messalli, {E. M.} and L. Quirino and A. Ragucci",
year = "2005",
language = "English",
volume = "32",
pages = "111--113",
journal = "Clinical and Experimental Obstetrics and Gynecology",
issn = "0390-6663",
publisher = "S.O.G. CANADA Inc.",
number = "2",

}

TY - JOUR

T1 - Local estrogen replacement therapy in postmenopausal atrophic vaginitis

T2 - Efficacy and safety of low dose 17β-estradiol vaginal tablets

AU - Mainini, G.

AU - Scaffa, C.

AU - Rotondi, M.

AU - Messalli, E. M.

AU - Quirino, L.

AU - Ragucci, A.

PY - 2005

Y1 - 2005

N2 - Purpose of investigation: To verify the effectiveness and safety of low-dose 17β-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis. Patients and methods: 325 postmenopausal women with atrophic vaginitis in estrogenic replacement therapy with 0.025 mg 17β-estradiol vaginal tablets, one application each day for two weeks, and a single application two times a week for the following 22 weeks (total treatment period: 24 weeks). Results: Most of the women reported an improvement of symptoms just after two weeks and minimal incidence of adverse reactions. No patients showed abnormal endometrial thickness and no one had to interrupt the treatment for abnormal uterine bleeding because of systemic absorption. Conclusion: Low-dose 17β-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis constitutes an extremely valid approach in terms of effectiveness and safety.

AB - Purpose of investigation: To verify the effectiveness and safety of low-dose 17β-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis. Patients and methods: 325 postmenopausal women with atrophic vaginitis in estrogenic replacement therapy with 0.025 mg 17β-estradiol vaginal tablets, one application each day for two weeks, and a single application two times a week for the following 22 weeks (total treatment period: 24 weeks). Results: Most of the women reported an improvement of symptoms just after two weeks and minimal incidence of adverse reactions. No patients showed abnormal endometrial thickness and no one had to interrupt the treatment for abnormal uterine bleeding because of systemic absorption. Conclusion: Low-dose 17β-estradiol vaginal tablets in the treatment of the postmenopausal atrophic vaginitis constitutes an extremely valid approach in terms of effectiveness and safety.

KW - 17β-estradiol vaginal tablets

KW - Atrophic vaginitis

KW - Estrogen replacement therapy

UR - http://www.scopus.com/inward/record.url?scp=23044494048&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23044494048&partnerID=8YFLogxK

M3 - Article

C2 - 16108394

AN - SCOPUS:23044494048

VL - 32

SP - 111

EP - 113

JO - Clinical and Experimental Obstetrics and Gynecology

JF - Clinical and Experimental Obstetrics and Gynecology

SN - 0390-6663

IS - 2

ER -